Initiator Pharma A/S (STO: INIT)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.80
-0.10 (-1.45%)
Dec 20, 2024, 5:29 PM CET

Initiator Pharma Statistics

Total Valuation

Initiator Pharma has a market cap or net worth of SEK 382.46 million. The enterprise value is 364.29 million.

Market Cap 382.46M
Enterprise Value 364.29M

Important Dates

The last earnings date was Friday, November 29, 2024.

Earnings Date Nov 29, 2024
Ex-Dividend Date n/a

Share Statistics

Initiator Pharma has 56.24 million shares outstanding. The number of shares has increased by 4.53% in one year.

Current Share Class n/a
Shares Outstanding 56.24M
Shares Change (YoY) +4.53%
Shares Change (QoQ) +2.14%
Owned by Insiders (%) 9.35%
Owned by Institutions (%) 12.01%
Float 36.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 15.96
P/TBV Ratio 16.01
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -22.55
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.79

Current Ratio 11.79
Quick Ratio 11.79
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -83.61% and return on invested capital (ROIC) is -49.03%.

Return on Equity (ROE) -83.61%
Return on Assets (ROA) -45.17%
Return on Capital (ROIC) -49.03%
Revenue Per Employee n/a
Profits Per Employee -5.39M
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.60% in the last 52 weeks. The beta is 0.75, so Initiator Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change -25.60%
50-Day Moving Average 7.04
200-Day Moving Average 8.30
Relative Strength Index (RSI) 43.01
Average Volume (20 Days) 34,466

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit -17.90M
Operating Income -24.39M
Pretax Income -23.49M
Net Income -16.16M
EBITDA n/a
EBIT -24.39M
Earnings Per Share (EPS) -0.30
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 18.17M
Total Debt n/a
Net Cash 18.17M
Net Cash Per Share 0.32
Equity (Book Value) 23.88M
Book Value Per Share 0.43
Working Capital 23.86M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.13M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Initiator Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.53%
Shareholder Yield -4.53%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a